Work

Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?

Year: 2002

Type: editorial

Source: International Journal of Cardiology

DOI: 10.1016/s0167-5273(02)00182-1

Authors: Paul R Kalra, James C.C Moon, Andrew J.S Coats

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2033557350

Cites: 8

Cited by: 294

Related to: 10